Results 241 to 250 of about 227,291 (309)

Primary Intracranial DICER-1 Mutant Sarcoma: A Systematic Review of Existing Literature from 2000 to 2024. [PDF]

Pak J Med Sci
Qadri HM, Ahmed U, Ahmed AA, Sajid T, Hassan A, Arshad MU, Chen PY, Bashir A.   +7 more
europepmc   +1 more source

Endovascular Stenting for Pulmonary Vein Stenosis Following Atrial Fibrillation Ablation: From Diagnosis to Intervention

Catheterization and Cardiovascular Interventions, EarlyView.
ABSTRACT Background Pulmonary vein stenosis (PVS) is an uncommon but serious complication of atrial fibrillation (AF) ablation, often misinterpreted as primary pulmonary disease. Timely identification is essential to prevent irreversible injury and to guide appropriate referral for interventional management. Case Presentations Through the discussion of
Cristina Aurigemma, Marco Busco, Francesco Bianchini, Gabriella Locorotondo, Francesca Graziani, Annalisa Pasquini, Enrico Romagnoli, Mattia Lunardi, Lazzaro Paraggio, Francesco Varone, Andrea Smargiassi, Bruno Iovene, Riccardo Marano, Carlo Trani, Francesco Burzotta   +14 more
wiley   +1 more source

Neoadjuvant Pembrolizumab Combined with Chemotherapy for Locally Advanced Resectable Oral and Oropharyngeal Squamous Cell Carcinomas: A Single-center Retrospective Study. [PDF]

J Cancer
Geng X, Zhao Y, Wu Y, Ma X, Xia R, Xu X, Ren G.   +6 more
europepmc   +1 more source

Modern management of phyllodes tumours: closing the gap between evidence and practice. [PDF]

Gland Surg
Rizk M, Mokbel K.
europepmc   +1 more source

Porous Organic Frameworks‐Based Nanomaterials in Colorectal Cancer Therapy: From Drug Delivery to Personalized Nano‐Vaccine

Cancer Nexus, EarlyView.
ABSTRACT Colorectal cancer (CRC), as the second most common cause of cancer death worldwide, has seen a significant increase in its incidence rate in recent years. However, the current major clinical treatment methods, such as surgery, chemotherapy and radiotherapy, still have certain limitations and are difficult to achieve a complete cure.
Xiaoyu Song, Hao Zhang, Yinghui Wang, Chao Luo   +3 more
wiley   +1 more source

Modern Management of the Axilla in HER2-Negative Hormone Receptor-Positive Early Breast Cancer Upfront Surgery: Toward De-Escalation and Individualization. [PDF]

Cancers (Basel)
Abahssain H, Pasquier D, Laabid K, Barani M, Borges S, Poitureau S, Bettache G, Nguyen TL, Bytha M, Rodriguez J, Lemaire A, Curigliano G, Souadka A.   +12 more
europepmc   +1 more source

Mechanisms of Resistance to Cancer Immunotherapy: A Host–Tumor Interaction Perspective; A Review Article

Cancer Nexus, EarlyView.
Mechanisms of resistance to cancer immunotherapy from a host–tumor interaction perspective. The central tumor cell is protected by multiple resistance mechanisms, including genetic mutations, epigenetic modifications, and metabolic alterations. The immunosuppressive tumor microenvironment features myeloid‐derived suppressor cells (MDSCs), regulatory T ...
Mohammed Elmujtba Adam Essa, Hamid Noori, Abdelkareem A. Ahmed   +2 more
wiley   +1 more source

Up-front Hypofractionated Radiotherapy Before Third-Generation Chemotherapy in Node-positive Breast Cancer: A Retrospective Comparative Study. [PDF]

In Vivo
Montagna A, Benevento I, D'Andrea B, Bianculli A, Tucciariello R, Metallo V, Schirò I, Virgilio T, Zeccola A, Lazzari G.   +9 more
europepmc   +1 more source

Real‐World Molecular Analyses May Overestimate Chemotherapy Benefit in HR‐Positive/HER2‐Negative Breast Cancer

Cancer Nexus, EarlyView.
ABSTRACT Large real‐world breast cancer datasets with molecular profiling are increasingly used to estimate the benefit of adjuvant chemotherapy in hormone receptor‐positive, HER2‐negative (HR+/HER2−) disease and are often interpreted alongside randomized trial data.
Mobina Shrestha, Patricia McNally, Priyanka Nagdev, Daniel Cruceta Reynoso, Amir Babu, Muhammad A. Israr   +5 more
wiley   +1 more source

The effect of postoperative chemotherapy on survival outcomes and a nomogram for predicting overall survival in chondroblastic osteosarcoma. [PDF]

Sci Rep
Li R, Wang H, Zheng W, Wang N, Ma Z, Wen S.   +5 more
europepmc   +1 more source